PRACTICAL ASPECTS OF OPHTHALMIC DRUG DEVELOPMENT

被引:10
作者
AKERS, MJ
SCHOENWALD, RD
MCGINITY, JW
机构
[1] ALCON LABS INC,FT WORTH,TX 76101
[2] UNIV TEXAS,COLL PHARM,AUSTIN,TX 78712
关键词
D O I
10.3109/03639047709055607
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:185 / 217
页数:33
相关论文
共 36 条
[1]  
ALLEN JH, 1968, MAYS DISEASES EYE, P37
[2]  
ARONSON SB, 1972, OCULAR INFLAMMATION, P74
[3]  
BEASLEY H, 1975, ARCH OPHTHALMOL-CHIC, V93, P184
[4]  
BENEDETTO DA, 1975, INVEST OPHTH VISUAL, V14, P887
[5]  
BOCK FC, 1970, AM J OPHTHALMOL, V69, P659
[6]  
Cadwallader D E, 1967, Am J Hosp Pharm, V24, P32
[7]   DROP SIZE AND INITIAL DOSING FREQUENCY PROBLEMS OF TOPICALLY APPLIED OPHTHALMIC DRUGS [J].
CHRAI, SS ;
MAKOID, MC ;
ERIKSEN, SP ;
ROBINSON, JR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (03) :333-338
[8]  
CHRAI SS, 1974, J PHARM SCI, V63, P1218, DOI 10.1002/jps.2600630810
[9]   LACRIMAL AND INSTILLED FLUID DYNAMICS IN RABBIT EYES [J].
CHRAI, SS ;
PATTON, TF ;
MEHTA, A ;
ROBINSON, JR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (07) :1112-1121
[10]   The cornea VII Permeability to weak electrolytes [J].
Cogan, DG ;
Hirsch, EO .
ARCHIVES OF OPHTHALMOLOGY, 1944, 32 (04) :276-282